GI quality reporting in action: Q&A with Dr. Bergein Overholt
Question: What system or process do you use in measuring and reporting quality data? Are PQRS measurements met by this system?
Bergein F. Overholt, MD, FACP, MACG: Our practice and ASCs have developed a comprehensive quality and value program that uses GIQuIC and gMed for reporting quality data. Physicians and staff work within this program to input data to GIQuIC for analysis. The resulting information is downloaded to our practice and used for internal assessment. PQRS reporting is met by GIQuIC. CMS has labeled such registries as GIQuIC and DHRP qualified clinical data registries.
Q: Are the new CMS ASC measures #9 and #10 measured and reported by the system you use?
BO: CMS ASC #9 and #10 data is captured in part by GIQuIC, but the CMS regulations require facilities to report these measures via a website administered by CMS, resulting in additional and significant manual effort to complete. The professional societies are currently urging CMS to incorporate the use of registries to achieve ASC quality reporting requirements so we in practice don't have to report the same data different ways, which requires duplicate effort and greater time.
Q: What are important steps for a practice/ASC to consider in developing a quality reporting system?
BO: Developing a quality reporting program is a significant commitment on the part of a practice or ASC. The following steps need to be done:
• Commitment to quality by the physicians, practice and ASC is the one critical and essential component of a Q&V program.
• Physician and administrative leadership. There has to be at least one "champion," particularly among the physicians.
• Allocation of staff. At least a half to one FTE computer-skilled nurse is required along with IT support and of course there is the time required by the physician leader. It should be compensated time.
• Financial support from the practice and ASC. It will require $100,000 to $150,000 to establish a Q&V program with the majority of costs attributed to staff and physician expenses.
• Reporting. Physicians must see the data results on an on-going basis. Only then will they know how they compare with peers and whether their performance is acceptable or needs improvement.
Q: What are the criteria you use to measure quality in your ASC?
BO: We use a combination of national benchmarks, averages from the national registry we use and two key patient satisfaction survey results. It is important to note that data needs to be submitted to and analyzed by a validated, outside third party. In our case we use GIQuIC for our endoscopic measurements and Healthstream for our ASC patient satisfaction scores. We consider patient satisfaction as a measure of quality, albeit a perceived measure. Specifically, our criteria in first time screening colonoscopies include:
Endoscopic quality measures:
• Adenoma detection rate in first time screening colonoscopy (national benchmark: male 25 percent or more; female 15 percent or more; combined 20 percent or more)
• Percent to cecum (photo documented; all patients)
• Percent compliance for a 10-year follow-up colonoscopy recommendation in an average risk individual with a normal screening colonoscopy
• Percent compliance for a five-year follow-up colonoscopy recommendation in an average risk patient with one or two non-high risk adenomas found at first time screening colonoscopy
Patient satisfaction, although subjective, is another quality measure we use:
• How would you rate the overall performance of this center on a scale of one to 10?
• Would you refer patients to this center? ___YES ___NO
Q: Are you able to negotiate quality measures with third parties?
BO: Yes, we negotiated an at-risk quality contract with a large insurance company. If we exceeded national and/or registry quality benchmarks (number one through four above) by a certain percentage, we would receive higher payments which, in part, were designed to help offset the costs of our Q&V program. We are in discussions with other insurance companies.
Q: Do they reward your practice for meeting quality goals and benchmarks?
BO: CMS is requiring reporting certain quality measures under PQRS, with the threat of a professional payment reduction beginning in 2015 if those measures are not reported. Providers may report quality measures to CMS through a validated registry preventing a reduction in reimbursement and also receive a small bonus payment in 2014 of 0.5 percent of total Medicare Part B fee for service patient reimbursement. Beginning in 2015, there is no bonus payment for satisfactorily meeting PQRS quality reporting requirements but a potential 1.5 percent to 2 percent cut in 2015 and beyond for failing to do so.
Q: Have you seen improvement in physicians meeting quality measures within your practice as a result of a quality program?
BO: Yes. Since implementation of our Q&V program, we have seen the ADR increase for some physicians and therefore our group average ADR has increased. As others have said before, physicians do not like to be in the bottom percentile of a quality measure. They will improve their performance if data shows them performing in a lower percentile group. The following chart "says it all" for our group.
The key for a practice to arrive at a place where data can be used internally and externally is to have your data submitted to and analyzed by a validated national registry.
More Articles on Gastroenterology:
100 statistics for gastroenterologists to know
AGA: 12 lower GI endoscopy coding changes to know for 2015
Hiring & firing: What gastroenterologists need to know about finding a stellar staff
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- 9 new ASCs and outpatient surgery centers in April 2016
- Joint Commission updates stance on texting orders
- 5 most read GI/endoscopy stories: April 25 - April 29
- American Academy of Arts and Sciences elects Dr. John Carethers: 4 things to know
- Tobira Therapeutics' drug safe for obese patients with health issues: 3 insights